New York Life Sciences Vacancy Rises to 32.5% Amid Surge in Venture Capital Funding
In the second quarter of 2026, New York's life sciences vacancy rate increased by 70 basis points to reach 32.5%, despite available lab space remaining steady at 700,000 square feet since June 2025. Venture capital funding in the sector surged to $1.9 billion during Q2—more than double compared to a year earlier—and NIH funding is on track for its typical annual total of around $3 billion. The Savills report highlights continued momentum, including AI-driven deals such as Anthropic's acquisition of Coefficient Bio for $400 million. However, the market faces challenges from excess lab supply and public-sector cutbacks, like a 75% reduction in New York City Economic Development Corp.'s life science workforce. While strong capital flows suggest long-term demand growth, landlords are currently constrained by high vacancy rates that limit pricing power. The key question is whether increased funding will translate into future leasing activity.
Topics: AI in biotech NIH funding vacancy venture_capital_funding